Abstract
Background: Meal variety promotes overconsumption by delaying sensory-specific satiety (SSS), the transient reduction in reward value of a recently consumed food. Despite its role in meal cessation, the neuroendocrine mechanisms that underlie SSS are largely unknown. Methods: Here, we developed a preclinical model of SSS wherein rats consume more of a different food compared with the same food presented again, leading to greater caloric intake. Using pharmacological and molecular approaches targeting the brainstem, we investigated the involvement of the satiation signal glucagon-like peptide-1 (GLP-1) in mediating SSS in male rats (n = 96) and in female rats (n = 85) across their estrous cycle. We also evaluated the sufficiency of the hormone estradiol to modulate GLP-1 and SSS. Results: In males, brainstem GLP-1 receptors (GLP-1Rs) were necessary for the SSS-induced decrease in same food intake, while agonizing brainstem GLP-1Rs was sufficient to attenuate overconsumption of the different food. Female rats showed SSS in an estrous cycle–dependent manner and did not consume more of the different food in diestrus-to-proestrus and proestrus-to-estrus. However, blockade of brainstem GLP-1Rs restored different food overconsumption. Furthermore, the brainstem's nucleus tractus solitarius and area postrema showed increased expression of the GLP-1 precursor glucagon (Gcg), during diestrus-to-proestrus and proestrus-to-estrus and greater Glp1r expression in proestrus-to-estrus. Similarly, 17β-estradiol injections in males not only increased Glp1r and Gcg expression but also reduced SSS. Conclusions: We identified a bidirectional role for brainstem GLP-1R signaling in modulating SSS, effects that are estrous cycle dependent. Moreover, our data indicate that estradiol regulates Glp1r and Gcg expression and likely influences SSS.
| Original language | English |
|---|---|
| Pages (from-to) | 249-259 |
| Number of pages | 11 |
| Journal | Biological Psychiatry |
| Volume | 98 |
| Issue number | 3 |
| DOIs | |
| State | Published - Aug 1 2025 |
Bibliographical note
Publisher Copyright:© 2025 Society of Biological Psychiatry
Funding
BCR and MRH receive research funding from Boehringer Ingelheim. MRH also receives funding from Pfizer, Gila Therapeutics, and Eli Lilly & Co. These funds were not used in support of the studies reported herein. BCR receives in-kind support from Oxford Nanopore Technologies that is not related to this project. All other authors report no biomedical financial interests or potential conflicts of interest. This work was supported by the National Institutes of Health (Grant Nos. DK115762 [to MRH] and DK137443 [to SVA]).
| Funders | Funder number |
|---|---|
| Eli Lilly | |
| Boehringer-Ingelheim | |
| Pfizer | |
| Gila Therapeutics | |
| National Institutes of Health (NIH) | DK115762, DK137443 |
Keywords
- Caloric intake
- Estradiol
- Estrous cycle
- GLP-1
- Nucleus tractus solitarius
- Sensory-specific satiety
ASJC Scopus subject areas
- Biological Psychiatry